Dulucq, S., Etienne, G., Morisset, S., Klein, E., Chollet, C., Robbesyn, F., . . . Mahon, F. (2019). Impact of second decline rate of BCR-ABL1 transcript on clinical outcome of chronic phase chronic myeloid leukemia patients on imatinib first-line. Annals of Hematology, 98(5), 1159-1169.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Dulucq, Stephanie, et al. "Impact of Second Decline Rate of BCR-ABL1 Transcript on Clinical Outcome of Chronic Phase Chronic Myeloid Leukemia Patients on Imatinib First-line."
Annals of Hematology 98, no. 5 (2019): 1159-1169.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Dulucq, Stephanie, et al. "Impact of Second Decline Rate of BCR-ABL1 Transcript on Clinical Outcome of Chronic Phase Chronic Myeloid Leukemia Patients on Imatinib First-line."
Annals of Hematology, vol. 98, no. 5, 2019, pp. 1159-1169.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.